Challenging our past paradigm in the management of epilepsy

Neurology

Volumn 55, Issue 11 SUPPL. 3, 2000, Pages

  Sachdeo, R ^a  

^a ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; NEW DRUG; OXCARBAZEPINE; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID;

ADD ON THERAPY; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; EPILEPSY; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; SIDE EFFECT;

ANTICONVULSANTS; EPILEPSY; HUMANS;

EID: 0034642341     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Clinical trial design for antiepileptic drugs
2. Hazards of inference: The active control investigation
3. Monotherapy trials of new antiepileptic drugs
4. A double-blind study comparing oxcarbazepine in patients with newly diagnosed, previously untreated epilepsy
5. A double-blind controlled clinical trial: Oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy
6. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy
7. A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy
8. Felbamate monotherapy: Controlled trial in patients with partial onset seizures
9. Topiramate monotherapy for partial onset seizures
10. Safety and efficacy of oxcarbazepine monotherapy
11. Oxcarbazepine monotherapy for partial-onset seizures: A multicenter, double-blind, clinical trial
12. Safety and efficacy of tiagabine HCL monotherapy in the treatment of partial seizures: High dose versus low dose
13. Comparison of carbamazepine, phenobarbital, phenytoin and primidone in partial and secondarily generalized tonic-clonic seizures
14. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults: The Department of Veterans Affairs Epilepsy Cooperative Study No 264 Group
15. Gabapentin monotherapy, II: A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures
16. Clinical efficacy of new antiepileptic drugs in refractory partial epilepsy: Experience in the United States with three novel drugs
17. Expanding antiepileptic drug options: Clinical efficacy of new therapeutic agents
18. Oxcarbazepine double-blind, randomized, placebo-control, monotherapy trial for partial seizures
19. Gabapentin monotherapy, I: An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures
20. Gabapentin monotherapy in patients with newly-diagnosed epilepsy: Results of double-blind, fixed dose study comparing three doses of gabapentin and open-label carbamazepine
21. Outcomes of add-on treatment with lamotrigine in partial epilepsy
22. Lamotrigine for generalized seizures associated with the Lernnox-Gastaut syndrome
23. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
24. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: A double-blind comparison with phenytoin
25. An active-control trial of lamotrigine monotherapy for partial seizures
26. Topiramate. Clinical profile in epilepsy